We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+11.08%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$134B
AUM Growth
+$14.8B
Cap. Flow
+$2.42B
Cap. Flow %
1.81%
Top 10 Hldgs %
25.29%
Holding
4,017
New
232
Increased
1,652
Reduced
1,816
Closed
191

Sector Composition

Rank Sector Weight
1 Technology 15.71%
2 Financials 9.02%
3 Healthcare 7.82%
4 Industrials 6.8%
5 Consumer Discretionary 5.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QDEC icon
3051
FT Vest Growth-100 Buffer ETF December
QDEC
$704M
$426K ﹤0.01%
+18,006
New +$417K
HYT icon
3052
BlackRock Corporate High Yield Fund
HYT
$1.37B
$425K ﹤0.01%
45,089
+847
+2% +$7.42K
ICMB icon
3053
Investcorp Credit Management BDC
ICMB
$12.3M
$425K ﹤0.01%
119,522
-30,442
-20% -$109K
VCV icon
3054
Invesco California Value Municipal Income Trust
VCV
$527M
$424K ﹤0.01%
43,266
-150
-0.3% -$1.34K
INTC icon
3055
PUT
Intel
INTC
$527B
$423K ﹤0.01%
+9,400
New +$382K
BATT icon
3056
Amplify Lithium & Battery Technology ETF
BATT
$124M
$422K ﹤0.01%
40,055
-6,118
-13% -$63.9K
CVI icon
3057
CVR Energy
CVI
$3.52B
$422K ﹤0.01%
+13,923
New +$440K
MCI
3058
Barings Corporate Investors
MCI
$342M
$420K ﹤0.01%
22,782
+993
+5% +$16.5K
VERA icon
3059
Vera Therapeutics
VERA
$2.08B
$418K ﹤0.01%
27,199
-1,346
-5% -$17.1K
CWK icon
3060
Cushman & Wakefield Ltd
CWK
$3.24B
$418K ﹤0.01%
38,725
-8,096
-17% -$67.4K
CWI icon
3061
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.88B
$418K ﹤0.01%
15,451
-691
-4% -$17.6K
RMTI icon
3062
Rockwell Medical
RMTI
$29.6M
$418K ﹤0.01%
22,098
+3,031
+16% +$56.9K
ASND icon
3063
Ascendis Pharma A/S
ASND
$16.8B
$417K ﹤0.01%
3,312
-43
-1% -$4.29K
ENFR icon
3064
Alerian Energy Infrastructure ETF
ENFR
$519M
$417K ﹤0.01%
18,064
+4,865
+37% +$109K
ISCV icon
3065
iShares Morningstar Small-Cap Value ETF
ISCV
$710M
$417K ﹤0.01%
7,036
+66
+0.9% +$3.49K
DDS icon
3066
Dillards
DDS
$9.93B
$415K ﹤0.01%
1,029
-18
-2% -$6.11K
CYH icon
3067
Community Health Systems
CYH
$410M
$414K ﹤0.01%
132,423
+4,680
+4% +$12.6K
ROOF
3068
DELISTED
NYLI CBRE NextGen Real Estate ETF
ROOF
$414K ﹤0.01%
20,288
-2,058
-9% -$38K
DVYE icon
3069
iShares Emerging Markets Dividend ETF
DVYE
$1.21B
$414K ﹤0.01%
15,633
+5,024
+47% +$125K
NPV icon
3070
Nuveen Virginia Quality Municipal Income Fund
NPV
$215M
$413K ﹤0.01%
38,301
+3,300
+9% +$32.9K
BMY icon
3071
CALL
Bristol-Myers Squibb
BMY
$130B
$413K ﹤0.01%
+7,500
New +$394K
MPA icon
3072
BlackRock MuniYield Pennsylvania Quality Fund
MPA
$144M
$412K ﹤0.01%
35,407
+2,805
+9% +$30.3K
BFK
3073
DELISTED
BlackRock Municipal Income Trust
BFK
$410K ﹤0.01%
40,755
+6,524
+19% +$61.6K
FRA icon
3074
BlackRock Floating Rate Income Strategies Fund
FRA
$392M
$410K ﹤0.01%
32,404
+5,852
+22% +$71.1K
SGML icon
3075
Sigma Lithium
SGML
$1.27B
$409K ﹤0.01%
12,956
-3,466
-21% -$96.7K

Similar funds

Raymond James & Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Raymond James & Associates held 4,017 positions worth $134B, up 12% from $119B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q4 2023 filing shows 232 new, 1,652 increased, 1,816 reduced and 191 closed positions. Its largest new stake was Delek US: 515,324 shares worth $13.3M. The largest sale was Pioneer Natural Resource Co., an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2023 buy was Delek US: 515,324 shares worth $13.3M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $219M increase.
  • Raymond James & Associates's biggest Q4 2023 reduction was Pioneer Natural Resource Co., cutting an estimated $124M.
  • Raymond James & Associates fully exited Kayne Anderson NextGen Energy & Infrastructure, Inc. in Q4 2023, selling an estimated $22.8M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $134B portfolio in Q4 2023.
  • Raymond James & Associates opened 232 new positions and closed 191 in Q4 2023.
  • Raymond James & Associates's portfolio value rose 12% quarter-over-quarter to $134B.

Based on Raymond James & Associates's 13F filing for Q4 2023, filed 16 Jan 2024.